Document is current

Any future updates will be listed below

Correction: A human Myogenin promoter modified to be highly active in alveolar rhabdomyosarcoma drives an effective suicide gene therapy

Crossref DOI link: https://doi.org/10.1038/s41417-020-00251-y

Published Online: 2020-11-11

Published Print: 2021-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark